Association Between Gut Dysbiosis and Sepsis-Induced Myocardial Dysfunction in Patients With Sepsis or Septic Shock

Objective Sepsis-induced myocardial dysfunction (SIMD) seriously affects the evolution and prognosis of the sepsis patient. The gut microbiota has been confirmed to play an important role in sepsis or cardiovascular diseases, but the changes and roles of the gut microbiota in SIMD have not been reported yet. This study aims to assess the compositions of the gut microbiota in sepsis or septic patients with or without myocardial injury and to find the relationship between the gut microbiota and SIMD. Methods The prospective, observational, and 1:1 matched case–control study was conducted to observe gut microbiota profiles from patients with SIMD (n = 18) and matched non-SIMD (NSIMD) patients (n = 18) by 16S rRNA gene sequencing. Then the relationship between the relative abundance of microbial taxa and clinical indicators and clinical outcomes related to SIMD was analyzed. The receiver operating characteristic (ROC) curves were used to evaluate the predictive efficiencies of the varied gut microbiota to SIMD. Results SIMD was associated with poor outcomes in sepsis patients. The beta-diversity of the gut microbiota was significantly different between the SIMD patients and NSIMD subjects. The gut microbiota profiles in different levels significantly differed between the two groups. Additionally, the abundance of some microbes (Klebsiella variicola, Enterobacteriaceae, and Bacteroides vulgatus) was correlated with clinical indicators and clinical outcomes. Notably, ROC analysis indicated that K. variicola may be a potential biomarker of SIMD. Conclusion Our study indicates that SIMD patients may have a particular gut microbiota signature and that the gut microbiota might be a potential diagnostic marker for evaluating the risk of developing SIMD.

[1]  Jingjuan Hu,et al.  Propionate alleviates myocardial ischemia-reperfusion injury aggravated by Angiotensin II dependent on caveolin-1/ACE2 axis through GPR41 , 2022, International Journal of Biological Sciences.

[2]  A. Mosig,et al.  Intestinal Stem Cell-on-Chip to Study Human Host-Microbiota Interaction , 2021, Frontiers in Immunology.

[3]  W. Chong,et al.  Roles of LncRNAs in Regulating Mitochondrial Dysfunction in Septic Cardiomyopathy , 2021, Frontiers in Immunology.

[4]  Song Chen,et al.  Evaluation of the Molecular Mechanisms of Sepsis Using Proteomics , 2021, Frontiers in Immunology.

[5]  Xiao Yang,et al.  Gut Microbial Metabolite Pravastatin Attenuates Intestinal Ischemia/Reperfusion Injury Through Promoting IL-13 Release From Type II Innate Lymphoid Cells via IL−33/ST2 Signaling , 2021, Frontiers in Immunology.

[6]  O. S. Obayori,et al.  Aerobic degradation of 2,4,6-trinitrophenol by Proteus sp. strain OSES2 obtained from an explosive contaminated tropical soil , 2021, Biodegradation.

[7]  Hao Liu,et al.  Gut Microbial Diversity in Female Patients With Invasive Mole and Choriocarcinoma and Its Differences Versus Healthy Controls , 2021, Frontiers in Cellular and Infection Microbiology.

[8]  Wenzhen Li,et al.  Blood volatile organic aromatic compounds concentrations across adulthood in relation to total and cause specific mortality: A prospective cohort study. , 2021, Chemosphere.

[9]  G. Pappas,et al.  Multidrug-Resistant (MDR) Klebsiella variicola Strains Isolated in a Brazilian Hospital Belong to New Clones , 2021, Frontiers in Microbiology.

[10]  T. van der Poll,et al.  Integrative Transkingdom Analysis of the Gut Microbiome in Antibiotic Perturbation and Critical Illness , 2021, mSystems.

[11]  S. Celin,et al.  Study on aerobic degradation of 2,4,6-trinitrotoluene (TNT) using Pseudarthrobacter chlorophenolicus collected from the contaminated site , 2021, Environmental Monitoring and Assessment.

[12]  X. Yang,et al.  The gut microbiota metabolite capsiate promotes Gpx4 expression by activating TRPV1 to inhibit intestinal ischemia reperfusion-induced ferroptosis , 2021, Gut microbes.

[13]  H. Bello-Toledo,et al.  Hypervirulent and hypermucoviscous extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Klebsiella variicola in Chile , 2020, Virulence.

[14]  B. Cooper,et al.  Impact of low blood culture usage on rates of antimicrobial resistance , 2020, The Journal of infection.

[15]  F. Shanahan,et al.  The Healthy Microbiome (What is the definition of a healthy gut microbiome?). , 2020, Gastroenterology.

[16]  S. Künzel,et al.  S100A8 and S100A9 are Important for Postnatal Development of Gut Microbiota and Immune System in Mice and Infants. , 2020, Gastroenterology.

[17]  L. Cerdeira,et al.  First report of hypermucoviscous Klebsiella variicola subsp. variicola causing primary endodontic infection. , 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[18]  W. Kim,et al.  Association between right ventricle dysfunction and poor outcome in patients with septic shock , 2020, Heart.

[19]  Zeyou Chen,et al.  Colonization of Mice With Amoxicillin-Associated Klebsiella variicola Drives Inflammation via Th1 Induction and Treg Inhibition , 2020, Frontiers in Microbiology.

[20]  J. Kalbfleisch,et al.  Endothelial HSPA12B Exerts Protection Against Sepsis-Induced Severe Cardiomyopathy via Suppression of Adhesion Molecule Expression by miR-126 , 2020, Frontiers in Immunology.

[21]  A. Benítez-Páez,et al.  Gut microbiota profiles in critically ill patients, potential biomarkers and risk variables for sepsis , 2020, Gut microbes.

[22]  R. Yao,et al.  Publication Trends of Research on Sepsis and Host Immune Response during 1999-2019: A 20-year Bibliometric Analysis , 2020, International journal of biological sciences.

[23]  Kuibao Li,et al.  Dysbiotic gut microbes may contribute to hypertension by limiting vitamin D production , 2019, Clinical cardiology.

[24]  N. Rodríguez-Medina,et al.  Klebsiella variicola: an emerging pathogen in humans , 2019, Emerging microbes & infections.

[25]  Xinting Pan,et al.  Gut Microbiota Disruption in Septic Shock Patients: A Pilot Study , 2018, Medical science monitor : international medical journal of experimental and clinical research.

[26]  Takuji Yamada,et al.  Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis , 2018, Circulation.

[27]  J. Ran,et al.  Short-term effects of ambient benzene and TEX (toluene, ethylbenzene, and xylene combined) on cardiorespiratory mortality in Hong Kong. , 2018, Environment international.

[28]  C. Schwanke,et al.  Impact of human aging and modern lifestyle on gut microbiota , 2018, Critical reviews in food science and nutrition.

[29]  F. Hugenholtz,et al.  The emerging role of the microbiota in the ICU , 2018, Critical Care.

[30]  P. Bork,et al.  The Human Gut Microbiome: From Association to Modulation , 2018, Cell.

[31]  C. H. Bang,et al.  Risk factors and outcomes of sepsis-induced myocardial dysfunction and stress-induced cardiomyopathy in sepsis or septic shock , 2018, Medicine.

[32]  T. van der Poll,et al.  Myocardial Injury in Patients With Sepsis and Its Association With Long-Term Outcome , 2018, Circulation. Cardiovascular quality and outcomes.

[33]  M. Kozioł-Montewka,et al.  Gut microbiome as a biomarker of cardiometabolic disorders. , 2017, Annals of agricultural and environmental medicine : AAEM.

[34]  K. Kashani,et al.  Prognostic impact of isolated right ventricular dysfunction in sepsis and septic shock: an 8-year historical cohort study , 2017, Annals of Intensive Care.

[35]  M. Hattori,et al.  Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure , 2017, PloS one.

[36]  Rob Knight,et al.  Extreme Dysbiosis of the Microbiome in Critical Illness , 2016, mSphere.

[37]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[38]  D. Shang,et al.  Acute cholecystitis associated with infection of Enterobacteriaceae from gut microbiota. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[39]  J. Goedert,et al.  Collection media and delayed freezing effects on microbial composition of human stool , 2015, Microbiome.

[40]  C. Huttenhower,et al.  Sequencing and beyond: integrating molecular 'omics' for microbial community profiling , 2015, Nature Reviews Microbiology.

[41]  Jesse R. Zaneveld,et al.  Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences , 2013, Nature Biotechnology.

[42]  M. Stiborová,et al.  Aerobic degradation of 2,4-dinitrotoluene by individual bacterial strains and defined mixed population in submerged cultures. , 2011, Journal of hazardous materials.

[43]  Hanbo Chen,et al.  VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R , 2011, BMC Bioinformatics.

[44]  O. Tasaki,et al.  Altered Gut Flora Are Associated with Septic Complications and Death in Critically Ill Patients with Systemic Inflammatory Response Syndrome , 2010, Digestive Diseases and Sciences.

[45]  Maria Karlsson,et al.  Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. , 2010, Cell host & microbe.

[46]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[47]  M. Pop,et al.  Metagenomic Analysis of the Human Distal Gut Microbiome , 2006, Science.

[48]  Yan-wen Shu,et al.  Fecal microbiota transplantation alleviates myocardial damage in myocarditis by restoring the microbiota composition , 2019, Pharmacological research.

[49]  E. Martínez-Romero,et al.  Klebsiella variicola, a novel species with clinical and plant-associated isolates. , 2004, Systematic and applied microbiology.